SSRN Top Downloads

View all papers in this subject matter classification

Read more about Top Downloads

Top Downloads For:

COVID-19 eJournal

Recent Top Papers (60 days)

As of: 14 Oct 2024 - 13 Dec 2024

Rank	Paper	Downloads
1.	Mental Health of Children and Adolescents in Times of Global Crises: Findings from the Longitudinal COPSY Study from 2020 to 2024 Anne Kaman, Michael Erhart, Janine Devine, Ann-Kathrin Napp, Franziska Reiss, Steven Behn and Ulrike Ravens-Sieberer University of Hamburg - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University of Hamburg - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg- Eppendorf, University Medical Center Hamburg- Eppendorf and University Medical Center Hamburg-Eppendorf - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics Date Posted: 04 Dec 2024 Last Revised: 05 Dec 2024	321
2.	A Phase 2/3 Trial to Investigate the Safety and Immunogenicity of Monovalent Omicron Jn.1-Adapted Bnt162b2 Covid-19 Vaccine in Adults ≥18 Years Old Oyeniyi Diya, Juleen Gayed, Francine S. Lowry, Hua Ma, Vishva Bangad, Federico Mensa, Jing Zou, Xuping Xie, Yanping Hu, Mark Cutler, more... Pfizer Vaccine Clinical Research and Development, Pfizer Vaccine Clinical Research and Development, Pfizer Inc Pennsylvania, Pfizer Inc Pennsylvania, Pfizer Inc Pennsylvania, BioNTech (Germany), University of Texas Medical Branch-Galveston - Department of Biochemistry and Molecular Biology, University of Texas Medical Branch-Galveston - Department of Biochemistry and Molecular Biology, University of Texas Medical Branch-Galveston - Department of Biochemistry and Molecular Biology, Pfizer Worldwide Research and Development Date Posted: 25 Oct 2024 Last Revised: 08 Nov 2024	245
3.	Youth Mental Health in Times of Global Crises: Evidence from the Longitudinal COPSY Study Anne Kaman, Janine Devine, Michael Erhart, Ann-Kathrin Napp, Franziska Reiss, Sophie Moeller, Fionna Zoellner, Steven Behn and Ulrike Ravens-Sieberer University of Hamburg - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg-Eppendorf - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University of Hamburg - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, University Medical Center Hamburg- Eppendorf, University Medical Center Hamburg- Eppendorf, University Medical Center Hamburg- Eppendorf, University Medical Center Hamburg- Eppendorf and University Medical Center Hamburg-Eppendorf - Department of Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics Date Posted: 04 Dec 2024 Last Revised: 04 Dec 2024	206
4.	The Immunogenicity, Reactogenicity, and Safety of a Bivalent mRNA or Protein-Based COVID-19 Vaccine Given as a Fourth Dose in Healthy Adults in Australia: a Randomised Controlled Trial Nadia Mazarakis, Zheng Quan Toh, Eleanor FG Neal, Kathryn Bright, Skyy Luu, Leanne Quah, Yan Yung Ng, Cattram D. Nguyen, John D. Hart, Lien Anh Ha Do, more... University of Melbourne - Infection and Immunity, University of Melbourne - Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, Murdoch Children's Research Institute, Murdoch Children's Research Institute, Murdoch Children's Research Institute, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity, University of Melbourne - Infection and Immunity Date Posted: 02 Oct 2024 Last Revised: 03 Oct 2024	68
5.	Early, Very High-Titre Convalescent Plasma Therapy in Clinically Vulnerable Individuals with Mild COVID-19: An International, Randomised, Open-Label Trial Simone Hoffmann, Eva Schrezenmeier, Maxime Desmarets, Fabian Halleck, Antoine Durrbach, Lynn Peters, Anna-Teresa Tremmel, Alina Seidel, Marita Führer, Friederike Bachmann, more... University of Ulm, Charité - Universitätsmedizin Berlin, University of Besançon - Université de Franche-Comté, Charité - Universitätsmedizin Berlin, Hôpitaux de Paris (AP-HP) - Hôpital Henri Mondor, University of Ulm, Stauferklinikum Schwäbisch Gmünd, University of Ulm, University of Ulm, Charité - Universitätsmedizin Berlin Date Posted: 09 Nov 2024 Last Revised: 14 Nov 2024	62
6.	Effects of Jak Inhibitors in Adults Hospitalized Due to Covid-19: A Systematic Review and Individual Participant Data Meta-Analysis of Randomized Clinical Trials Alain Amstutz, Stefan Schandelmaier, Hannah Ewald, Benjamin Speich, Johannes M. Schwenke, Christof Schönenberger, Stephan Schobinger, Thomas Agoritsas, Kay M. Tomashek, Seema U. Nayak, more... Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, University of Basel, University of Basel - University Hospital Basel, Basel University - CLEAR Methods Center, University of Basel - University Hospital Basel, Basel University - CLEAR Methods Center, University Hospitals of Geneva, Government of the United States of America - National Institute of Allergy and Infectious Diseases, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID) Date Posted: 03 Oct 2024 Last Revised: 03 Oct 2024	60
7.	Sars-Cov-2 Conjugate Vaccine Elicits Robust Immune Responses that Can Protect Against Evolving Variants Melanie Carroll, Heather Fox, Anh Tran, Fataneh Karandish, Leonardo Rojas, Gowri Chellappan, Geetha Karengil, Brent Fall, Mary Whalen, John Langston, more... Inventprise Inc, affiliation not provided to SSRN, National Research Council Canada, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN Date Posted: 18 Oct 2024 Last Revised: 18 Oct 2024	50
8.	Myguide Long Covid: An Online Self-Management Tool for People with Long Covid Hiten Naik, Kyla Pongratz, Michelle Malbeuf, Sonya Kung, Lori Last, Asuka Sugiyama, Esther Khor, Marlee McGuire, Adeera Levin and Karen C. Tran affiliation not provided to SSRN, Government of Canada - Provincial Health Services Authority, Providence Health Care, Government of Canada - Provincial Health Services Authority, Government of Canada - Provincial Health Services Authority, Government of Canada - Provincial Health Services Authority, Government of Canada - Provincial Health Services Authority, Government of Canada - Provincial Health Services Authority, University of British Columbia (UBC) - Department of Medicine and affiliation not provided to SSRN Date Posted: 31 Oct 2024 Last Revised: 01 Nov 2024	47
9.	Under-Reporting of SARS-CoV-2 Infections in 27 Countries, 2020–2022 Mustapha Mustapha, Kanae Togo, Hannah Volkman, Jingyan Yang, Alon Yehoshua, Manuela Di Fusco, John M. McLaughlin and Jennifer Nguyen Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. and Pfizer, Inc. Date Posted: 09 Nov 2024 Last Revised: 09 Nov 2024	46
10.	SARS-CoV-2 ORF10 Promotes COVID-19 Pathogenesis Jeffrey Allen Haltom, Nídia Sequeira Trovão, Joseph W. Guarnieri, Vincent Pan, Urminder Singh, Sergey Tsoy, Collin A. O'Leary, Yaron Bram, Gabrielle A. Widjaja, Zimu Cen, more... Iowa State University, National Institutes of Health - Fogarty International Center, University of Pennsylvania - Children's Hospital of Philadelphia, National Institutes of Health, Iowa State University, Cornell University - Weill Cornell Medicine, Iowa State University, Weill Cornell Medicine - Division of Gastroenterology and Hepatology, University of Pennsylvania - Children's Hospital of Philadelphia, University of Pennsylvania - Children's Hospital of Philadelphia Date Posted: 26 Sep 2024 Last Revised: 18 Oct 2024	44

All Time Top Papers

As of: 02 Jan 1997 - 13 Dec 2024

Rank	Paper	Downloads
1.	Serious Adverse Events of Special Interest Following mRNA Vaccination in Randomized Trials Joseph Fraiman, Juan Erviti, Mark Jones, Sander Greenland, Patrick Whelan, Robert M. Kaplan and Peter Doshi Louisiana State University - Lallie Kemp Regional Medical Center, Navarre Health Service, Bond University - Institute for Evidence-Based Healthcare, University of California, Los Angeles (UCLA) - Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles (UCLA), Stanford University and University of Maryland - School of Pharmacy Date Posted: 23 Jun 2022 Last Revised: 09 Sep 2022	120,189
2.	Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study Peter Nordström, Marcel Ballin and Anna Nordström Uppsala University - Department of Public Health and Caring Sciences, Uppsala University - Department of Public Health and Caring Sciences and Umeå University - Unit of Geriatric Medicine Date Posted: 25 Oct 2021 Last Revised: 05 Dec 2022	118,638
3.	Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam Nguyen Van Vinh Chau, Nghiem My Ngoc, Lam Anh Nguyet, Vo Minh Quang, Nguyen Thi Han Ny, Dao Bach Khoa, Nguyen Thanh Phong, Le Mau Toan, Nguyen Thi Thu Hong, Nguyen Thi Kim Tuyen, more... Hospital for Tropical Diseases, Hospital for Tropical Diseases, Hospital of Tropical Diseases - Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Hospital of Tropical Diseases - Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Hospital for Tropical Diseases, Hospital for Tropical Diseases, Hospital of Tropical Diseases - Oxford University Clinical Research Unit, Hospital of Tropical Diseases - Oxford University Clinical Research Unit Date Posted: 11 Oct 2021 Last Revised: 11 May 2023	99,480
4.	Temperature, Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19 Mohammad M. Sajadi, Parham Habibzadeh, Augustin Vintzileos, Shervin Shokouhi, Fernando Miralles-Wilhelm and Anthony Amoroso Institute of Human Virology at the University of Maryland School of Medicine, Shiraz University of Medical Sciences, University of Maryland - College Park, Infectious Diseases and Tropical Medicine Research, Shahid Beheshti University of Medical Sciences, University of Maryland - College Park and Institute of Human Virology at the University of Maryland School of Medicine Date Posted: 09 Mar 2020 Last Revised: 22 Aug 2021	97,689
5.	Impact of Temperature and Relative Humidity on the Transmission of COVID-19: A Modeling Study in China and the United States Jingyuan Wang, Ke Tang, Kai Feng, Xin Lin, Weifeng Lv, Kun Chen and Fei Wang Beihang University (BUAA), Institute of Economics, School of Social Sciences, Tsinghua University, Institute of Economics, School of Social Sciences, Tsinghua University, Beihang University (BUAA) - Department of Computer Science, Beihang University, University of Connecticut and Cornell University Date Posted: 10 Mar 2020 Last Revised: 28 Nov 2022	71,879
6.	Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, Lily Yin Weckx, Pedro M. Folegatti, Parvinder K. Aley, Brian John Angus, Vicky Baillie, Shaun L. Barnabas, Qasim E. Bhorat, more... University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - Vaccines and Infectious Diseases Analytics Research Unit, Federal University of São Paulo (UNIFESP), University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand, Stellenbosch University - Family Centre for Research with Ubuntu, Soweto Clinical Trials Centre Date Posted: 01 Feb 2021 Last Revised: 19 Nov 2021	52,423
7.	Randomised Clinical Trials of COVID-19 Vaccines: Do Adenovirus-Vector Vaccines Have Beneficial Non-Specific Effects? Christine Stabell Benn, Frederik Schaltz-Buchholzer, Sebastian Nielsen, Mihai G. Netea and Peter Aaby University of Southern Denmark - Odense Patient Data Explorative Network (OPEN), Statens Serums Institut - Bandim Health Project, University of Southern Denmark - Odense Patient Data Explorative Network (OPEN), Radboud University Nijmegen - Radboud Center for Infectious Diseases (RCI) and Bandim Health Project, INDEPTH Network Date Posted: 05 Apr 2022 Last Revised: 20 Jun 2022	33,394
8.	In Silico Investigation of Komaroviquinone as a Potential Inhibitor of Sars-Cov-2 Main Protease (Mpro): Molecular Docking, Molecular Dynamics, and Qm/Mm Approaches Samuel José Mendes dos Santos and Antoninho Valentini Federal Institute of Education, Science and Technology of Rio Grande do Sul and Federal University of Ceara Date Posted: 30 May 2023 Last Revised: 24 Nov 2023	32,045
9.	Safety and Immunogenicity Report from the Com-COV Study – a Single-Blind Randomised Non-Inferiority Trial Comparing Heterologous And Homologous Prime-Boost Schedules with An Adenoviral Vectored and mRNA COVID-19 Vaccine Xinxue Liu, Robert H. Shaw, Arabella SV Stuart, Melanie Greenland, Tanya Dinesh, Samuel Provstgaard-Morys, Elizabeth Clutterbuck, Maheshi N. Ramasamy, Parvinder K. Aley, Yama Farooq Mujadidi, more... University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group Date Posted: 25 Jun 2021 Last Revised: 01 Nov 2021	25,319
10.	Effectiveness of First Dose of COVID-19 Vaccines Against Hospital Admissions in Scotland: National Prospective Cohort Study of 5.4 Million People Eleftheria Vasileiou, Colin R. Simpson, Chris Robertson, Ting Shi, Steven Kerr, Utkarsh Agrawal, Ashley Akbari, Stuart Bedston, Jillian Beggs, Declan Bradley, more... University of Edinburgh - Asthma UK Centre for Applied Research, Victoria University of Wellington - School of Health, University of Strathclyde - Department of Mathematics & Statistics, University of Edinburgh - Centre for Global Health, University of Edinburgh - Usher Institute of Population Health Sciences and Informatics, University of St. Andrews - School of Medicine, Swansea University - Health Data Research UK, Swansea University - Population Data Science, BREATHE – The Health Data Research Hub for Respiratory Health, Queen’s University Belfast - Public Health Agency Date Posted: 19 Feb 2021 Last Revised: 28 Nov 2022	21,434

All content on this site: Copyright © 2024 Elsevier Inc., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.

We use cookies to help provide and enhance our service and tailor content.

To learn more, visit .